RHOCLONE 150MCG INJECTION

RHOCLONE 150mcg Injection is a prescription medicine used to treat chronic immune thrombocytopenia (ITP), a condition where the body has dangerously low platelet counts. It contains romiplostim, a thrombopoietin receptor agonist that stimulates the bone marrow to produce more platelets. Doctors prescribe this injection for patients who do not respond well to other ITP treatments such as corticosteroids or immunoglobulins.

This injection works by activating receptors in the bone marrow that increase platelet production naturally. Higher platelet levels help reduce symptoms like easy bruising, nosebleeds, bleeding gums, and internal bleeding risks. RHOCLONE 150 mcg Injection is given under medical supervision, usually once weekly, and the dosage is adjusted based on platelet response to ensure safe and effective treatment.

RHOCLONE 150 mcg Injection plays an important role in improving the quality of life for patients with chronic ITP. It helps maintain safer platelet levels, reduces hospital visits for bleeding episodes, and supports long-term disease management. Patients should follow their doctor’s advice, attend regular blood tests, and inform healthcare providers about any other medical conditions or medications before using this injection.

Product Features

• Contains Romiplostim to boost platelet production
• Used for chronic immune thrombocytopenia (ITP)
• Helps reduce bleeding and bruising risk
• Administered weekly under medical supervision
• Supports long-term platelet count management

How It Helps

• Stimulates bone marrow to produce more platelets
• Reduces risk of bleeding and bruising
• Improves platelet levels in chronic ITP patients
• Enhances overall treatment response and quality of life